Find University Hospitals Doctors

Barry Effron, MD

Barry Effron, MD



211 Ratings 0 Reviews



Accepting New Patients

Primary Location

UH Cleveland Medical Center
11100 Euclid Ave
Cleveland, OH 44106

View All (2)

Schedule an Appointment

First Available: Thursday, Mar 18


Are you pregnant or have you had a baby in the last 2 months?


  • Director, Evaluation and Prevention Center, UH Cleveland Medical Center
  • Director, Cardio-Oncology Program, UH Cleveland Medical Center
  • Associate Professor, CWRU School of Medicine


  • Cardiology
  • Cardiomyopathy
  • Cardio-Oncology
  • Coronary Artery Disease (CAD)
  • Lipid Management
  • Preventive Cardiovascular Medicine
  • Valvular Heart Disease


Watch to find out more about this University Hospitals physician.

Languages Spoken


Office Locations

UH Cleveland Medical Center

11100 Euclid Ave
Cleveland OH, 44106

Get Directions

UH Minoff Health Center at Chagrin Highlands

3909 Orange Pl
Beachwood OH, 44122

Get Directions

Patient Experience Reviews

4.9 out of 5

211 Ratings

Board Certifications

  • Cardiovascular Disease - American Board of Internal Medicine
  • Internal Medicine - American Board of Internal Medicine


Research Fellowship | Cardiovascular Disease
Cardiovascular Disease - University Of Wisconsin-Madison (1984 - 1985)

Residency | Internal Medicine/Chief Resident
Internal Medicine/Chief Resident - University Hospitals Of Cleveland (1983 - 1984)

Fellowship | Cardiovascular Disease
Cardiovascular Disease - University Hospitals Of Cleveland (1981 - 1983)

Residency | Internal Medicine
Internal Medicine - University Hospitals Of Cleveland (1980 - 1981)

Residency | Internal Medicine
Internal Medicine - Ohio State University Hospital (1979 - 1980)

Internship | Internal Medicine
Internal Medicine - Ohio State University Hospital (1978 - 1979)

Medical Education
The Ohio State University College Of Medicine (1978)

Cornell University (1975)

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Barry Effron disclosed the following Outside Relationships with Industry:

  • - Boehringer Ingelheim Pharmaceutical, Inc. (BIPI) - Consulting
  • - Amgen, Inc. - Honoraria